AGP Executive Report
Last update: an hour agoPharma & Devices: OncoSil Medical won US FDA approval for its OncoSil™ targeted radiation device for unresectable, non-metastatic distal cholangiocarcinoma, a rare bile duct cancer, with an estimated A$80m US market. Cancer Drug Development: AstraZeneca reported positive late-stage results for a two-pill combo (Tagrisso plus Orpathys) aimed at lung cancer patients whose disease resists Tagrisso, potentially enabling broader global approvals. AI in Medicine: A new £20m Cambridge hub will use AI plus human tissue disease models (including organoids) to speed drug development and reduce reliance on animal research. Healthcare Access & Policy: Karnataka announced 7.5% rural-government-school reservation for professional courses, including medical and engineering. Workforce & Systems: Saudi Arabia’s registered healthcare workforce topped 801,000 in 2025 as training capacity and graduates rose. Public Health & Safety: Maldives’ medicine shortages were blamed on weak import and stock-management, with an ERP/e-logistics rollout planned to improve real-time availability. Community Health: A family-owned Woodland pharmacy was vandalized in a suspected hate crime targeting its LGBTQ display. Caregiving: A “Savvy Senior” guide focused on what Medicare covers for caregivers supporting a parent after stroke.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
